NCT04462952View on ClinicalTrials.gov

Study of Adavosertib(AZD1775) in Japanese Patients With Advanced Solid Tumours

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

June 24, 2020

Primary Completion Date

September 22, 2021

Study Completion Date

September 22, 2021

Conditions

Advanced Solid Tumours

Interventions

DRUG

Adavosertib (AZD1775)

Adavosertib taken orally

Trial Locations (1)

104-0045

Research Site, Chūōku

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY